Polsinelli’s health care mergers and acquisitions team helps buyers, sellers and investors close deals, ensure compliance and unlock post-closing value. Powered by one of the nation’s elite health care practices and consistently ranked among the most active M&A teams in the industry, we seamlessly align corporate, regulatory, reimbursement, real estate and operational counsel to drive speed, efficiency and closing certainty across transactions.

Twice recognized as Health Care Law Firm of the Year by Best Law Firms and nationally recognized as a top 10 Most Active Law Firm by PitchBook, we advise on hundreds of mergers, acquisitions, joint ventures, recapitalizations and other strategic health care transactions each year. From entrepreneurs to private equity sponsors, publicly traded companies to nonprofits, clients trust us to help them scale, innovate and get deals done.

Regulatory Strategy in Every Stage of the Deal

With unmatched deal volume, deep regulatory insight and an unwavering commitment to client service, Polsinelli is your partner in strategic health care growth. We embed regulatory strategy at every stage of the transaction lifecycle to help protect your investment and accelerate your path to growth. Our team:

  • Structures transactions to minimize regulatory delays and maximize post-acquisition reimbursement opportunities.
  • Conducts targeted health care regulatory due diligence and resolves compliance issues in real time to keep deals moving.
  • Supports post-close integration to align operations, ensure ongoing compliance and enhance profitability.

Health Care M&A Experience Across Sectors

Our experience spans both emerging and established markets, grounded in a nuanced understanding of each sector’s regulatory, operational and business challenges. 

We offer strategic guidance across the health care continuum, with strength in the sectors shaping today’s landscape:

Whether the market is shifting or scaling, we help clients anticipate change — and grow through it.

National Recognition
Slide 1 of 4
Related Capabilities
Commercial Contracts & TransactionsCorporate & TransactionalDistressed Health CareJoint Ventures & Strategic AlliancesMechanical Engineering & Medical Devices Patent ProsecutionPrivate Credit & Direct LendingPrivate EquitySecurities & Corporate FinanceVenture Capital & Emerging Growth Companies
Publications
All Publications
Hospice M&A rebounds but compliant assets in short supply – Dealspeak North America
Andrew Voss discusses the rebound in hospice M&A activity, noting that buyers are increasingly viewing hospice providers as part of a broader continuum of care rather than standalone businesses. He highlights that investors are prioritizing disciplined platform-building through strategic add-on acquisitions, while placing greater emphasis on compliance, operational stability and regulatory readiness than on growth alone. Voss also notes that heightened regulatory scrutiny and extended diligence processes have made high-quality, compliant hospice assets increasingly scarce, driving greater selectivity among buyers and influencing deal structures and valuations.
Read More
OHCA Publishes Draft Regulations Implementing AB 1415 to Capture Health Care Transactions with Private Equity, Hedge Funds and MSOs
Key Takeaways OHCA has published draft regulations that expand its pre-transaction notice requirements to transactions involving private equity groups, hedge funds, certain management services organizations and newly created entities entering into transactions with health care entities. OHCA also proposed revised standards and procedures in its existing regulations, including adding information and documents to be disclosed and refining the procedures for conducting Cost and Market Impact Reviews. Among other focuses, the proposed regulations demonstrate OHCA’s interest in details of the arrangements between private equity groups and California health care entities and the impact of transactions on real estate where health care is delivered. Some of the new standards and requirements bear a notable resemblance to language used in some terms of the recent proposed
Read More